Inhibition of Trichinella spiralis Membrane‐Associated Progesterone Receptor (MAPR) Results in the Reduction of Worm Burden

Abstract

Trichinella spiralis (T. spiralis), a nematode parasite, is the major cause of Trichinellosis, a zoonotic disease. A key role of MAPR in the reproductive system is to maintain pregnancy. Previous studies found antihormone (P4 and RU486) drug design and vaccine therapy of recombinant protein (rTs-MAPRC2) to control T. spiralis infection. The current study investigates the inhibitory effects of different ratios of antibody against Ts-MAPRC2 on the development of muscle larvae (ML) and newborn larvae (NBL). First, we performed indirect immunofluorescence assays (IIFA) and examined the effects of rTs-MAPRC2-Ab on ML and NBL in vitro as well as in vivo. After-ward, siRNA-Ts-MAPRC2 was transfected into T. spiralis muscle larvae. Following that, Ts-MAPRC2 protein was detected by Western Blotting and mRNA levels were determined by qPCR. Also, we assessed whether siRNA-treated NBLs were infective by analyzing muscle larvae burden (MLs). Our Result showed rTs-MAPRC2-Ab greatly inhibited the activity of the Ts-MAPRC2 gene in ML and NBL of T. spiralis. rTs-MAPRC2-Ab reduced larval infectivity and survival in the host in a dose-dependent manner (1:50, 1:200, 1:800 dilutions). Further, siR-NA-Ts-MAPRC2 effectively silenced the Ts-MAPRC2 gene in muscle larvae (ML) by in vitro, as well as in new-born larvae (NBL) of T. spiralis by in vivo. In addition, siRNA-Ts-MAPRC2 (siR-NA180, siRNA419, siRNA559) reduced host larval survival and infectivity significantly. The effect of siRNA on larval development, survival, and infectivity was significantly reduced when the Ts-MAPRC2 gene was knocked down. This study, therefore, suggests that Ts-MAPRC2 might be a novel molecular target that might be useful in the development of vaccines against T. spiralis infection.